Cargando…
LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.
Both lymphokine activated killer (LAK) cells and specific cytotoxic T lymphocytes appear to play a role in tumour immunity. Tumour infiltrating lymphocytes (TIL) which display a CD56+ phenotype (both CD3+ and CD3-) are also likely to possess anti-tumour activity. We have previously described a 120 k...
Autores principales: | Ferrarini, M., Ferrero, E., Fortis, C., Poggi, A., Zocchi, M. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971538/ https://www.ncbi.nlm.nih.gov/pubmed/1700922 |
Ejemplares similares
-
Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro.
por: Gallagher, G., et al.
Publicado: (1989) -
γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy
por: Poggi, Alessandro, et al.
Publicado: (2014) -
Antigen Presenting Cells and Stromal Cells Trigger Human Natural Killer Lymphocytes to Autoreactivity: Evidence for the Involvement of Natural Cytotoxicity Receptors (NCR) and NKG2D
por: Poggi, Alessandro, et al.
Publicado: (2006) -
Two Distinct Mechanisms Involved in the Infiltration of Lymphocytes into Tumors
por: Shijubo, Noriharu, et al.
Publicado: (1988) -
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
por: Courjal, F., et al.
Publicado: (1996)